ALGS vs GL · rev $3.6M vs P/E 10, $10.26B cap
Aligos Therapeutics Inc (ALGS) versus Globe Life Inc (GL) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Globe Life Inc (GL) is a insurance - life company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
GL does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Not investment advice. Open the ALGS and GL stock pages for the full models.
Not investment advice.